- call +1-201-465-4211
- email sales@mrinsights.biz
Intrauterine contraceptive device (IUD) is a T-shaped, small-sized, birth control device that is inserted into woman’s uterus to prevent pregnancy. These devices are highly effective, economical, and safe birth control devices. IUDs are considered 99% safe in preventing pregnancy. The contraceptive effect of IUDs is attributable to the localized inflammation that occurs after insertion. The inflammatory reaction in the uterus produces substances that are poisonous for sperms. This affects fertilization. Intrauterine devices can be used immediately after delivery, as they do not affect breastfeeding. These can also be used after abortion. IUDs provide several advantages. They prevent pregnancy for a long time; reduce the chances of ectopic pregnancy; and do not cause discomfort during sex. Once an IUD is removed, the user can quickly return to fertility.
Two types of intrauterine devices available in the U.S. are copper-releasing IUDs and progesterone-releasing IUDs. Copper-releasing IUDs function by releasing copper that is wrapped around the base. The released copper initiates inflammatory reaction in the uterus, which prevents fertilization of the egg. Copper-releasing IUDs are approved for use up to 10 years. Progesterone-releasing IUDs release progestin, which acts by thickening the cervical mucus and creating a barrier to sperms. It also renders the uterus lining unreceptive to implantation of the egg.
Scope of the Report:
This report focuses on the Intrauterine Contraceptive Devices (IUCD) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Intrauterine Contraceptive Devices (IUCD) is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Bayer Healthcare AG
Teva Pharmaceutical Industries Ltd
Actavis PLC
Medicines360
Trimedic Supply Network Ltd
Medisafe Distribution Inc
Pace Pharmaceuticals Inc
DKT International
Melbea AG
Pregna International Limited
Ocon Medical Ltd
SMB Corporation
Mona Lisa N.V
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Non-hormonal
Hormonal
Inert
Market Segment by Applications, can be divided into
T Shapes
V Shapes
Others
There are 15 Chapters to deeply display the global Intrauterine Contraceptive Devices (IUCD) market.
Chapter 1, to describe Intrauterine Contraceptive Devices (IUCD) Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Intrauterine Contraceptive Devices (IUCD), with sales, revenue, and price of Intrauterine Contraceptive Devices (IUCD), in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Intrauterine Contraceptive Devices (IUCD), for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Intrauterine Contraceptive Devices (IUCD) market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Intrauterine Contraceptive Devices (IUCD) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Intrauterine Contraceptive Devices (IUCD) Introduction
1.2 Market Analysis by Type
1.2.1 Non-hormonal
1.2.2 Hormonal
1.2.3 Inert
1.3 Market Analysis by Applications
1.3.1 T Shapes
1.3.2 V Shapes
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bayer Healthcare AG
2.1.1 Business Overview
2.1.2 Intrauterine Contraceptive Devices (IUCD) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bayer Healthcare AG Intrauterine Contraceptive Devices (IUCD) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Teva Pharmaceutical Industries Ltd
2.2.1 Business Overview
2.2.2 Intrauterine Contraceptive Devices (IUCD) Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Teva Pharmaceutical Industries Ltd Intrauterine Contraceptive Devices (IUCD) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Actavis PLC
2.3.1 Business Overview
2.3.2 Intrauterine Contraceptive Devices (IUCD) Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Actavis PLC Intrauterine Contraceptive Devices (IUCD) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Medicines360
2.4.1 Business Overview
2.4.2 Intrauterine Contraceptive Devices (IUCD) Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Medicines360 Intrauterine Contraceptive Devices (IUCD) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Trimedic Supply Network Ltd
2.5.1 Business Overview
2.5.2 Intrauterine Contraceptive Devices (IUCD) Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Trimedic Supply Network Ltd Intrauterine Contraceptive Devices (IUCD) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Medisafe Distribution Inc
2.6.1 Business Overview
2.6.2 Intrauterine Contraceptive Devices (IUCD) Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Medisafe Distribution Inc Intrauterine Contraceptive Devices (IUCD) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Pace Pharmaceuticals Inc
2.7.1 Business Overview
2.7.2 Intrauterine Contraceptive Devices (IUCD) Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Pace Pharmaceuticals Inc Intrauterine Contraceptive Devices (IUCD) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 DKT International
2.8.1 Business Overview
2.8.2 Intrauterine Contraceptive Devices (IUCD) Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 DKT International Intrauterine Contraceptive Devices (IUCD) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Melbea AG
2.9.1 Business Overview
2.9.2 Intrauterine Contraceptive Devices (IUCD) Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Melbea AG Intrauterine Contraceptive Devices (IUCD) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Pregna International Limited
2.10.1 Business Overview
2.10.2 Intrauterine Contraceptive Devices (IUCD) Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Pregna International Limited Intrauterine Contraceptive Devices (IUCD) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Ocon Medical Ltd
2.11.1 Business Overview
2.11.2 Intrauterine Contraceptive Devices (IUCD) Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Ocon Medical Ltd Intrauterine Contraceptive Devices (IUCD) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 SMB Corporation
2.12.1 Business Overview
2.12.2 Intrauterine Contraceptive Devices (IUCD) Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 SMB Corporation Intrauterine Contraceptive Devices (IUCD) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Mona Lisa N.V
2.13.1 Business Overview
2.13.2 Intrauterine Contraceptive Devices (IUCD) Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Mona Lisa N.V Intrauterine Contraceptive Devices (IUCD) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Intrauterine Contraceptive Devices (IUCD) Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Intrauterine Contraceptive Devices (IUCD) Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Intrauterine Contraceptive Devices (IUCD) Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Intrauterine Contraceptive Devices (IUCD) Manufacturer Market Share in 2017
3.3.2 Top 6 Intrauterine Contraceptive Devices (IUCD) Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Intrauterine Contraceptive Devices (IUCD) Market Analysis by Regions
4.1 Global Intrauterine Contraceptive Devices (IUCD) Sales, Revenue and Market Share by Regions
4.1.1 Global Intrauterine Contraceptive Devices (IUCD) Sales and Market Share by Regions (2013-2018)
4.1.2 Global Intrauterine Contraceptive Devices (IUCD) Revenue and Market Share by Regions (2013-2018)
4.2 North America Intrauterine Contraceptive Devices (IUCD) Sales and Growth Rate (2013-2018)
4.3 Europe Intrauterine Contraceptive Devices (IUCD) Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Intrauterine Contraceptive Devices (IUCD) Sales and Growth Rate (2013-2018)
4.5 South America Intrauterine Contraceptive Devices (IUCD) Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Intrauterine Contraceptive Devices (IUCD) Sales and Growth Rate (2013-2018)
5 North America Intrauterine Contraceptive Devices (IUCD) by Countries
5.1 North America Intrauterine Contraceptive Devices (IUCD) Sales, Revenue and Market Share by Countries
5.1.1 North America Intrauterine Contraceptive Devices (IUCD) Sales and Market Share by Countries (2013-2018)
5.1.2 North America Intrauterine Contraceptive Devices (IUCD) Revenue and Market Share by Countries (2013-2018)
5.2 United States Intrauterine Contraceptive Devices (IUCD) Sales and Growth Rate (2013-2018)
5.3 Canada Intrauterine Contraceptive Devices (IUCD) Sales and Growth Rate (2013-2018)
5.4 Mexico Intrauterine Contraceptive Devices (IUCD) Sales and Growth Rate (2013-2018)
6 Europe Intrauterine Contraceptive Devices (IUCD) by Countries
6.1 Europe Intrauterine Contraceptive Devices (IUCD) Sales, Revenue and Market Share by Countries
6.1.1 Europe Intrauterine Contraceptive Devices (IUCD) Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Intrauterine Contraceptive Devices (IUCD) Revenue and Market Share by Countries (2013-2018)
6.2 Germany Intrauterine Contraceptive Devices (IUCD) Sales and Growth Rate (2013-2018)
6.3 UK Intrauterine Contraceptive Devices (IUCD) Sales and Growth Rate (2013-2018)
6.4 France Intrauterine Contraceptive Devices (IUCD) Sales and Growth Rate (2013-2018)
6.5 Russia Intrauterine Contraceptive Devices (IUCD) Sales and Growth Rate (2013-2018)
6.6 Italy Intrauterine Contraceptive Devices (IUCD) Sales and Growth Rate (2013-2018)
7 Asia-Pacific Intrauterine Contraceptive Devices (IUCD) by Countries
7.1 Asia-Pacific Intrauterine Contraceptive Devices (IUCD) Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Intrauterine Contraceptive Devices (IUCD) Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Intrauterine Contraceptive Devices (IUCD) Revenue and Market Share by Countries (2013-2018)
7.2 China Intrauterine Contraceptive Devices (IUCD) Sales and Growth Rate (2013-2018)
7.3 Japan Intrauterine Contraceptive Devices (IUCD) Sales and Growth Rate (2013-2018)
7.4 Korea Intrauterine Contraceptive Devices (IUCD) Sales and Growth Rate (2013-2018)
7.5 India Intrauterine Contraceptive Devices (IUCD) Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Intrauterine Contraceptive Devices (IUCD) Sales and Growth Rate (2013-2018)
8 South America Intrauterine Contraceptive Devices (IUCD) by Countries
8.1 South America Intrauterine Contraceptive Devices (IUCD) Sales, Revenue and Market Share by Countries
8.1.1 South America Intrauterine Contraceptive Devices (IUCD) Sales and Market Share by Countries (2013-2018)
8.1.2 South America Intrauterine Contraceptive Devices (IUCD) Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Intrauterine Contraceptive Devices (IUCD) Sales and Growth Rate (2013-2018)
8.3 Argentina Intrauterine Contraceptive Devices (IUCD) Sales and Growth Rate (2013-2018)
8.4 Colombia Intrauterine Contraceptive Devices (IUCD) Sales and Growth Rate (2013-2018)
9 Middle East and Africa Intrauterine Contraceptive Devices (IUCD) by Countries
9.1 Middle East and Africa Intrauterine Contraceptive Devices (IUCD) Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Intrauterine Contraceptive Devices (IUCD) Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Intrauterine Contraceptive Devices (IUCD) Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Intrauterine Contraceptive Devices (IUCD) Sales and Growth Rate (2013-2018)
9.3 UAE Intrauterine Contraceptive Devices (IUCD) Sales and Growth Rate (2013-2018)
9.4 Egypt Intrauterine Contraceptive Devices (IUCD) Sales and Growth Rate (2013-2018)
9.5 Nigeria Intrauterine Contraceptive Devices (IUCD) Sales and Growth Rate (2013-2018)
9.6 South Africa Intrauterine Contraceptive Devices (IUCD) Sales and Growth Rate (2013-2018)
10 Global Intrauterine Contraceptive Devices (IUCD) Market Segment by Type
10.1 Global Intrauterine Contraceptive Devices (IUCD) Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Intrauterine Contraceptive Devices (IUCD) Sales and Market Share by Type (2013-2018)
10.1.2 Global Intrauterine Contraceptive Devices (IUCD) Revenue and Market Share by Type (2013-2018)
10.2 Non-hormonal Sales Growth and Price
10.2.1 Global Non-hormonal Sales Growth (2013-2018)
10.2.2 Global Non-hormonal Price (2013-2018)
10.3 Hormonal Sales Growth and Price
10.3.1 Global Hormonal Sales Growth (2013-2018)
10.3.2 Global Hormonal Price (2013-2018)
10.4 Inert Sales Growth and Price
10.4.1 Global Inert Sales Growth (2013-2018)
10.4.2 Global Inert Price (2013-2018)
11 Global Intrauterine Contraceptive Devices (IUCD) Market Segment by Application
11.1 Global Intrauterine Contraceptive Devices (IUCD) Sales Market Share by Application (2013-2018)
11.2 T Shapes Sales Growth (2013-2018)
11.3 V Shapes Sales Growth (2013-2018)
11.4 Others Sales Growth (2013-2018)
12 Intrauterine Contraceptive Devices (IUCD) Market Forecast (2018-2023)
12.1 Global Intrauterine Contraceptive Devices (IUCD) Sales, Revenue and Growth Rate (2018-2023)
12.2 Intrauterine Contraceptive Devices (IUCD) Market Forecast by Regions (2018-2023)
12.2.1 North America Intrauterine Contraceptive Devices (IUCD) Market Forecast (2018-2023)
12.2.2 Europe Intrauterine Contraceptive Devices (IUCD) Market Forecast (2018-2023)
12.2.3 Asia-Pacific Intrauterine Contraceptive Devices (IUCD) Market Forecast (2018-2023)
12.2.4 South America Intrauterine Contraceptive Devices (IUCD) Market Forecast (2018-2023)
12.2.5 Middle East and Africa Intrauterine Contraceptive Devices (IUCD) Market Forecast (2018-2023)
12.3 Intrauterine Contraceptive Devices (IUCD) Market Forecast by Type (2018-2023)
12.3.1 Global Intrauterine Contraceptive Devices (IUCD) Sales Forecast by Type (2018-2023)
12.3.2 Global Intrauterine Contraceptive Devices (IUCD) Market Share Forecast by Type (2018-2023)
12.4 Intrauterine Contraceptive Devices (IUCD) Market Forecast by Application (2018-2023)
12.4.1 Global Intrauterine Contraceptive Devices (IUCD) Sales Forecast by Application (2018-2023)
12.4.2 Global Intrauterine Contraceptive Devices (IUCD) Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Intrauterine Contraceptive Devices (IUCD) Picture
Table Product Specifications of Intrauterine Contraceptive Devices (IUCD)
Figure Global Sales Market Share of Intra
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
